4840 - Department of Health: Performance Standards (Answered)

Steve Baker
To ask the Secretary of State for Health, what metrics are used to measure the performance of his Medicines, Pharmacy and Industry unit.

George Freeman

Medicines Pharmacy and Industry Group (MPIG) is part of the Department’s Innovation, Growth and Technology Directorate, and leads policy for the Department on pharmaceuticals, the medicines supply chain, and the role of pharmacies (including prescription charges). MPIG is responsible for:

- the delivery of the medicines pricing schemes including the Pharmaceutical Price Regulation Scheme;

- the delivery of frameworks for medicines procurement in secondary care;

- sponsorship role for two of the Department’s arm’s length bodies;

- the National Institute for Health and Care Excellence; and

- the Medicines and Healthcare products Regulatory Agency.

The key objective of MPIG is to support the safe, efficient and effective access to and use of medicines in the National Health Service.

The delivery of MPIG against plan is assessed internally through the Department’s Quarterly Corporate Accountability Review system. The overall financial position and performance of the Department is published in the Departmental Annual Report.

In addition the Department publishes, on a quarterly basis, the quarterly net payments and sales information relating to the Pharmaceutical Price Regulation Scheme at: